CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

about

CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.Karyopherins in cancer.LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer

P2860

Q42232513-D43EAB5E-8A7C-40F0-8EAD-A6030FE38103 Q50134836-BF15991F-8368-48B5-BCC8-63FEC1E2A02F Q58718402-BE7891EB-D486-4155-984A-FF4553367193

P2860

CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Item

http://www.wikidata.org/entity/Q38946743

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

CAS (CSE1L) signaling pathway ...... d target for targeted therapy.

@en

type

Item

label

CAS (CSE1L) signaling pathway ...... d target for targeted therapy.

@en

prefLabel

CAS (CSE1L) signaling pathway ...... d target for targeted therapy.

@en

P1476

CAS (CSE1L) signaling pathway ...... d target for targeted therapy.

@en

P2093

Ming-Chung Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1

Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2

Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor

hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

The human CAS protein which is homologous to the CSE1 yeast chromosome segregation gene product is associated with microtubules and mitotic spindle

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

P2888

s13277-016-5301-x

P304

13077-13090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-016-5301-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046593458

http://www.w3.org/2001/XMLSchema#string

P698

27596143

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

about

P2860

P2860

CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921